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CORRECTION
In: “Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein”
(Delis KT, Knaggs AL, and Khodabakhsh P. J Vasc Surg 2004;40:1174-83).
On page 1176, Fig 1 is incorrect. The following is the correct figure:
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Fig 1. Schematic representation of thigh extension (Giacomini vein) of small saphenous vein (SSV) in limbs with a
typical saphenopopliteal junction (A) and in limbs with a high or a very high SSV termination (B). See Methods for
definitions. Epitomized are the single or multiple endings (see Table III) of Giacomini vein. Percentage attached to
named veins represents cumulative occurrence in limbs with (A) a typical saphenopopliteal junction alone (236 of 301;
great saphenous vein, 33% [78 of 236]; posterior thigh muscle veins, 17% [40 of 236]; femoral vein, 8% [19 of 236];
popliteal vein, 100% [236 of 236]) and (B) with a high or a very high SSV termination alone (65 of 301; great
saphenous vein, 42% [27 of 65]; profunda femoral vein, 11% [7 of 65]; posterior thigh muscle veins, 27% [18 of 65];
femoral vein, 14% [9 of 65]). Differences in cumulative proportions not statistically significant. (Please note the possible
extension of Giacomini vein at the top of the thigh.) Giac V; Giacomini vein.
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